Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-01

FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution from Micro Labs Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride ophthalmic solution (Dorzolamide hydrochloride)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION (DORZOLAMIDE HYDROCHLORIDE)